Exane Derivatives’s Phathom Pharmaceuticals PHAT Stock Holding History

Exane Derivatives’s Portfolio PHAT Stock Details PHAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$94K	Buy
2022 Q1	$79.9K	Buy
2021 Q4	$99.5K	Hold
2021 Q3	$162K	Buy
2021 Q2	$96.6K	Buy
2021 Q1	$73.8K	Sell
2020 Q4	$87.3K	Hold
2020 Q3	$96.3K	Sell
2020 Q2	$91.4K	Sell
2020 Q1	$80.1K	Buy